Assessment of JC virus DNA in blood and urine from natalizumab-treated patients-Reference-Cited by-同舟云学术

Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

Published:2010-08-24 Issue:3 Volume:68 Page:304-310
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Rudick Richard A.,O'Connor Paul W.,Polman Chris H.,Goodman Andrew D.,Ray Soma S.,Griffith Nancy M.,Jurgensen Stephanie A.,Gorelik Leonid,Forrestal Fiona,Sandrock Alfred W.,Goelz Susan E.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference17 articles.

1. Progressive multifocal leukoencephalopathy;Åstrom;Brain,1958

2. Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy);ZuRhein;Prog Med Virol,1969

3. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals;Agostini;J Clin Microbiol,1996

4. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors;Egli;J Infect Dis,2009

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JC polyomavirus: a short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence;Expert Review of Molecular Diagnostics;2023-02-01

2. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy;Viruses;2022-06-08

3. High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients;Multiple Sclerosis and Related Disorders;2020-11

4. Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring;Frontiers in Immunology;2020-09-24

5. Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions;Viruses;2020-09-01